Immediate Impact

4 from Science/Nature 58 standout
Sub-graph 1 of 23

Citing Papers

Ulcerative colitis
2023 Standout
Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease
2023 Standout
5 intermediate papers

Works of Annese being referenced

Prevention of post‐operative recurrence of Crohn’s disease requires adequate mucosal concentration of mesalazine
1999
Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
1999

Author Peers

Author Last Decade Papers Cites
Annese 219 91 36 129 116 10 365
Brian P. Riff 227 117 14 64 127 13 378
David Ong 118 38 23 115 31 18 345
D R Shreeve 226 104 20 99 26 16 391
D M Sedgwick 130 23 34 149 34 15 360
G. D. Barr 129 48 6 120 37 13 393
Gavin Barr 153 59 9 203 27 15 308
Kin Fah Chin 167 99 21 45 89 15 388
L. Crocellà 185 56 5 109 86 14 329
Dror Wasserman 125 67 24 115 15 14 361
B. Nordenvall 135 26 4 266 74 13 372

All Works

Loading papers...

Rankless by CCL
2026